CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 1, 2012, Pages 113-124

  Valente, Anthony J ^a   Clark, Robert A ^a   Siddesha, Jalahalli M ^b   Siebenlist, Ulrich ^c   Chandrasekar, Bysani ^b,d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Act1; Cardiac hypertrophy; Fibrosis; NADPH oxidase; RAAS; TRAF3IP2

Indexed keywords

ANGIOTENSIN II; CONNECTION TO IKK AND SAPK JNK PROTEIN; GELATINASE B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; MEMBRANE PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE TRANSLOCATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; CELLS, CULTURED; COLLAGEN; ENDOMYOCARDIAL FIBROSIS; GENE EXPRESSION; INTERLEUKIN-18; MALE; MATRIX METALLOPROTEINASE 9; MEMBRANE GLYCOPROTEINS; MICE; MYOCYTES, CARDIAC; NADPH OXIDASE; NF-KAPPA B; RAC1 GTP-BINDING PROTEIN; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; TRANSCRIPTION FACTOR AP-1;

ANIMALIA; MUS;

EID: 84861994443     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.04.009     Document Type: Article

References (45)

1. Haywood G.A., Gullestad L., Katsuya T., Hutchinson H.G., Pratt R.E., Horiuchi M., et al. AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation Mar 4 1997, 95(5):1201-1206.
2. Haq S., Choukroun G., Lim H., Tymitz K.M., del Monte F., Gwathmey J., et al. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation Feb 6 2001, 103(5):670-677.
3. Baker K.M., Booz G.W., Dostal D.E. Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol 1992, 54:227-241.
4. Zablocki D., Sadoshima J. The one-two punch: knocking out angiotensin II in the heart. J Clin Invest Apr 1 2010, 120(4):1028-1031.
5. Shanmugam P., Valente A.J., Prabhu S.D., Venkatesan B., Yoshida T., Delafontaine P., et al. Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy. J Mol Cell Cardiol Jun 2011, 50(6):928-938.
6. Wosniak J., Santos C.X., Kowaltowski A.J., Laurindo F.R. Cross-talk between mitochondria and NADPH oxidase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells. Antioxid Redox Signal Jun 2009, 11(6):1265-1278.
7. Sano M., Fukuda K., Sato T., Kawaguchi H., Suematsu M., Matsuda S., et al. ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ Res Oct 12 2001, 89(8):661-669.
8. Maejima Y., Kuroda J., Matsushima S., Ago T., Sadoshima J. Regulation of myocardial growth and death by NADPH oxidase. J Mol Cell Cardiol Mar 2011, 50(3):408-416.
9. Nakagami H., Takemoto M., Liao J.K. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol Jul 2003, 35(7):851-859.
10. Hingtgen S.D., Tian X., Yang J., Dunlay S.M., Peek A.S., Wu Y., et al. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol Genomics Aug 16 2006, 26(3):180-191.
11. Bendall J.K., Cave A.C., Heymes C., Gall N., Shah A.M. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation Jan 22 2002, 105(3):293-296.
12. Freund C., Schmidt-Ullrich R., Baurand A., Dunger S., Schneider W., Loser P., et al. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo. Circulation May 10 2005, 111(18):2319-2325.
13. Kudoh S., Komuro I., Mizuno T., Yamazaki T., Zou Y., Shiojima I., et al. Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats. Circ Res Jan 1997, 80(1):139-146.
14. Gordon J.W., Shaw J.A., Kirshenbaum L.A. Multiple facets of NF-kappaB in the heart: to be or not to NF-kappaB. Circ Res Apr 29 2011, 108(9):1122-1132.
15. Leonardi A., Chariot A., Claudio E., Cunningham K., Siebenlist U. CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. Proc Natl Acad Sci U S A Sep 12 2000, 97(19):10494-10499.
16. Li X., Commane M., Nie H., Hua X., Chatterjee-Kishore M., Wald D., et al. Act1, an NF-kappa B-activating protein. Proc Natl Acad Sci U S A Sep 12 2000, 97(19):10489-10493.
17. Liu C., Qian W., Qian Y., Giltiay N.V., Lu Y., Swaidani S., et al. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci Signal 2009, 2(92):ra63.
18. Tone M., Thompson S.A., Tone Y., Fairchild P.J., Waldmann H. Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. J Immunol Dec 15 1997, 159(12):6156-6163.
19. Chandrasekar B., Mummidi S., Claycomb W.C., Mestril R., Nemer M. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. J Biol Chem Feb 11 2005, 280(6):4553-4567.
20. Woldbaek P.R., Sande J.B., Stromme T.A., Lunde P.K., Djurovic S., Lyberg T., et al. Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice. Am J Physiol Heart Circ Physiol Aug 2005, 289(2):H708-H714.
21. Majumdar G., Rooney R.J., Johnson I.M., Raghow R. Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy. Physiol Genomics Dec 16 2011, 43(24):1319-1333.
22. Platis A., Yu Q., Moore D., Khojeini E., Tsau P., Larson D. The effect of daily administration of IL-18 on cardiac structure and function. Perfusion Jul 2008, 23(4):237-242.
23. Claudio E., Sonder S.U., Saret S., Carvalho G., Ramalingam T.R., Wynn T.A., et al. The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J Immunol Feb 1 2009, 182(3):1617-1630.
24. Prabhu S.D., Chandrasekar B., Murray D.R., Freeman G.L. beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation May 2 2000, 101(17):2103-2109.
25. Venkatachalam K., Prabhu S.D., Reddy V.S., Boylston W.H., Valente A.J., Chandrasekar B. Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury. J Biol Chem Mar 20 2009, 284(12):7853-7865.
26. Myhre O., Andersen J.M., Aarnes H., Fonnum F. Evaluation of the probes 2',7'-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem Pharmacol May 15 2003, 65(10):1575-1582.
27. Reddy V.S., Prabhu S.D., Mummidi S., Valente A.J., Venkatesan B., Shanmugam P., et al. Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activation. Am J Physiol Heart Circ Physiol Oct 2010, 299(4):H1242-54.
28. Hordijk P.L. Regulation of NADPH oxidases: the role of Rac proteins. Circ Res Mar 3 2006, 98(4):453-462.
29. Satoh M., Ogita H., Takeshita K., Mukai Y., Kwiatkowski D.J., Liao J.K. Requirement of Rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci U S A May 9 2006, 103(19):7432-7437.
30. Pracyk J.B., Tanaka K., Hegland D.D., Kim K.S., Sethi R., Rovira I.I., et al. A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy. J Clin Invest Sep 1 1998, 102(5):929-937.
31. Mauro C., Vito P., Mellone S., Pacifico F., Chariot A., Formisano S., et al. Role of the adaptor protein CIKS in the activation of the IKK complex. Biochem Biophys Res Commun Sep 12 2003, 309(1):84-90.
32. Kalra D., Sivasubramanian N., Mann D.L. Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway. Circulation May 7 2002, 105(18):2198-2205.
33. Shifera A.S., Friedman J.M., Horwitz M.S. IKK gamma (NEMO) is involved in the coordination of the AP-1 and NF-kappa B pathways. Mol Cell Biochem Mar 2008, 310(1-2):181-190.
34. Colston J.T., Boylston W.H., Feldman M.D., Jenkinson C.P., de la Rosa S.D., Barton A., et al. Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload. Biochem Biophys Res Commun Mar 9 2007, 354(2):552-558.
35. Murray D.R., Mummidi S., Valente A.J., Yoshida T., Somanna N.K., Delafontaine P., et al. beta2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo. J Mol Cell Cardiol Jan 2012, 52(1):206-218.
36. Kang Z., Altuntas C.Z., Gulen M.F., Liu C., Giltiay N., Qin H., et al. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity Mar 26 2010, 32(3):414-425.
37. Qian Y., Liu C., Hartupee J., Altuntas C.Z., Gulen M.F., Jane-Wit D., et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol Mar 2007, 8(3):247-256.
38. Sonder S.U., Saret S., Tang W., Sturdevant D.E., Porcella S.F., Siebenlist U. IL-17-induced NF-kappaB activation via CIKS/Act1: physiologic significance and signaling mechanisms. J Biol Chem Apr 15 2011, 286(15):12881-12890.
39. Onishi R.M., Park S.J., Hanel W., Ho A.W., Maitra A., Gaffen S.L. SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction. J Biol Chem Oct 22 2010, 285(43):32751-32759.
40. Bulek K, Liu C, Swaidani S, Wang L, Page RC, Gulen MF, et al. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat Immunol Sep;12(9):844-52.
41. Hunyady L., Catt K.J. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol May 2006, 20(5):953-970.
42. AbdAlla S., Lother H., el Massiery A., Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med Sep 2001, 7(9):1003-1009.
43. Naka T., Sakoda T., Doi T., Akagami T., Tsujino T., Masuyama T., et al. Mechanical stretch induced interleukin-18 (IL-18) expression through Angiotensin subtype 1 receptor (AT1R) and endothelin-1 in cardiomyocytes. Prep Biochem Biotechnol 2008, 38(2):201-212.
44. Johar S., Cave A.C., Narayanapanicker A., Grieve D.J., Shah A.M. Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J Jul 2006, 20(9):1546-1548.
45. Haudek S.B., Cheng J., Du J., Wang Y., Hermosillo-Rodriguez J., Trial J., et al. Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J Mol Cell Cardiol Sep 2010, 49(3):499-507.